AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis

AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis

Tezspire has shown significant reduction in nasal polyp size and congestion in a study. It's being evaluated for severe chronic rhinosinusitis with nasal polyps and approved for severe asthma. Further research on its effectiveness for COPD is ongoing.

Read More

Did you find this insightful?